Maze Therapeutics, Inc. ($MAZE)
Filing Information
| Accession Number | 0002050172-26-000009 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 4, 2026 |
| Document Date | Feb 2, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
45,000
Total Value
$846,633.75
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, R&D & CMO | Common Stock | โ | Feb 2, 2026 | Exercise/Conversion | 15,000 | $10.42 | $156,300.00 | 15,000 | Direct | โ | View Details | |
President, R&D & CMO | Common Stock | โ | Feb 2, 2026 | Sale | 600 | $44.20 | $26,523.00 | 14,400 | Direct | โ | View Details | |
President, R&D & CMO | Common Stock | โ | Feb 2, 2026 | Sale | 8,364 | $45.89 | $383,816.43 | 6,036 | Direct | โ | View Details | |
President, R&D & CMO | Common Stock | โ | Feb 2, 2026 | Sale | 5,936 | $46.37 | $275,271.32 | 100 | Direct | โ | View Details | |
President, R&D & CMO | Common Stock | โ | Feb 2, 2026 | Sale | 100 | $47.23 | $4,723.00 | 0 | Direct | โ | View Details | |
President, R&D & CMO | Stock Option (Right to Buy) | Derivative | Feb 2, 2026 | Exercise/Conversion | 15,000 | $0.00 | $0.00 | 297,407 | Direct | โ | View Details |